Natural interferon α treatment and interferon α receptor 2 levels in acute hepatitis C

Digestive Diseases and Sciences

Volumn 49, Issue 2, 2004, Pages 289-294

  Ohata, Kazuyuki ^a,b   Yano, Koji ^a   Yatsuhashi, Hiroshi ^a   Daikoku, Manabu ^a   Koga, Michiaki ^a   Eguchi, Katsumi ^a   Yano, Michitami ^a  

^a NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Acute hepatitis C; Hepatic IFNAR2; Natural interferon

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; ALPHA INTERFERON RECEPTOR 2; UNCLASSIFIED DRUG; VIRUS RNA;

ACUTE HEPATITIS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; RNA ISOLATION;

ACUTE DISEASE; ADULT; ANTIVIRAL AGENTS; CASE-CONTROL STUDIES; FEMALE; HEPATITIS C; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; LIVER; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROTEIN ISOFORMS; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, INTERFERON; RETROSPECTIVE STUDIES;

EID: 1642359521     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:DDAS.0000017453.79349.46     Document Type: Article

References (33)

1. Fried MW, Hoofnagle JH: Therapy of hepatitis C. Semin Liver Dis 15:82-91, 1995
2. Bonis PA, Ioannidis JP, Cappelleri JC, Kaplan MM, Lau J: Correlation of biochemical response to interferon alfa with histological improvement in hepatitis C: A meta-analysis of diagnostic test characteristics. Hepatology 26:1035-1044, 1997
3. Manns MP, McHutchison JG, Gordon SC, et al.: Peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 358:958-965, 2001
4. Ferenci P, Brunner H, Nachbaur K, et al.: Combination of interferon induction therapy and ribavirin in chronic hepatitis C. Hepatology 34:1006-1011, 2001
5. Mizukoshi E, Kaneko S, Yanagi M, et al.: Expression of interferon alpha/beta receptor in the liver of chronic hepatitis C patients. J Med Virol 56:217-223, 1998
6. Yatsuhashi H, Fujino T, Matsumoto T, Inoue O, Koga M, Yano M: Immunohistochemical analysis of hepatic interferon alpha-beta receptor level: Relationship between receptor expression and response to interferon therapy in patients with chronic hepatitis C. J Hepatol 30:995-1003, 1999
7. Aach RD, Stevens CE, Hollinger FB, et al.: Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med 325:1325-1329, 1991
8. Wang JT, Wang TH, Sheu JC, Lin JT, Wang CY, Chen DS: Post-transfusion hepatitis revisited by hepatitis C antibody assays and polymerase chain reaction. Gastroenterology 103:609-616, 1992
9. Alter MJ, Margolis HS, Krawczynski K, et al.: The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 327:1899-1905, 1992
10. Tanaka E, Kiyosawa K: Natural history of acute hepatitis C. J Gastroenterol Hepatol 15:E97-E104, 2000
11. Omata M, Yokosuka O, Takano S, et al.: Resolution of acute hepatitis C after therapy with natural beta interferon. Lancet 338:914-915, 1991
12. Takano S, Satomura Y, Omata M: Effects of interferon beta on non-A, non-B acute hepatitis: A prospective, randomized, controlled-dose study. Japan Acute Hepatitis Cooperative Study Group. Gastroenterology 107:805-811, 1994
13. Vogel W: Treatment of acute hepatitis C virus infection. J Hepatol 31:189-192, 1999
14. Lampertico P, Rumi M, Romeo R, et al.: A multicenter randomized controlled trial of recombinant interferon-alpha 2b in patients with acute transfusion-associated hepatitis C. Hepatology 19:19-22, 1994
15. Ohnishi K, Nomura F, Nakano M: Interferon therapy for acute post-transfusion non-A, non-B hepatitis: Response with respect to antihepatitis C virus antibody status. Am J Gastroenterol 86:1041-1049, 1991
16. Palmovic D, Kurelac I, Crnjakovic-Palmovic J: The treatment of acute post-transfusion hepatitis C with recobinant interferon-alpha. Infection 22:222-223, 1994
17. Viladomiu L, Genesca J, Esteban JI, et al.: Interferon-alpha in acute posttransfusion hepatitis C: A randomized, controlled trial. Hepatology 15:767-769, 1992
18. Hwang SJ, Lee SD, Chan CY, Lu RH, Lo KJ: A randomized controlled trial of recombinant interferon alpha-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C. J Hepatol 21:831-836, 1994
19. Camma C, Almasio P, Craxi A: Interferon as treatment for acute hepatitis C. A meta-analysis. DigDis Sci 41:1248-1255, 1996
20. Quin JW: Interferon therapy for acute hepatitis C viral infection - A review by meta-analysis. Aust NZ J Med 27:611-617, discussion 617-618, 1997
21. Thevenot T, Regimbeau C, Ratziu V, Leroy V, Opolon P, Poynard T: Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 update. J Viral Hepatol 8:48-62, 2001
22. Calleri G, Colombatto P, Gozzelino M, et al.: Natural beta interferon in acute type-C hepatitis patients: A randomized controlled trial. Ital J Gastroenterol Hepatol 30:181-184, 1998
23. Okamoto H, Sugiyama Y, Okada S, et al.: Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. J Gen Virol 73:673-679, 1992
24. Okamoto H, Tokita H, Sakamoto M, et al.: Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol 74:2385-2390, 1993
25. Simmonds P: Viral heterogeneity of the hepatitis C virus. J Hepatol 31:54-60, 1999
26. Davis GL: Current therapy for chronic hepatitis C. Gastroenterology 118:S104-S114, 2000
27. Jaeckel E, Cornberg M, Wedemeyer H, et al.: Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 345:1452-1457, 2001
28. Orland JR, Wright TL, Cooper S: Acute hepatitis C. Hepatology 33:321-327, 2001
29. Vogel W, Graziadei I, Umlauft F, et al.: High-dose interferon-alpha2b treatment prevents chronicity in acute hepatitis C: a pilot study. Dig Dis Sci 41:81S-85S, 1996
30. Gursoy M, Gur G, Arslan H, Ozdemir N, Boyacioglu S: Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment. J Viral Hepatol 8:70-77, 2001
31. Toyoda H, Sakamoto H, Mizuno T, Horiguchi Y, Nakano H: Eradication of hepatitis C virus 1b by interferon in a health care worker with acute hepatitis following needlestick transmission from a patient with chronic hepatitis C unresponsive to interferon. Scand J Gastroenterol 35:1117-1120, 2000
32. Novick D, Cohen B, Rubinstein M: The human interferon alpha/beta receptor: Characterization and molecular cloning Cell 77:391-400, 1994
33. Yatsuhashi H, Yamasaki K, Aritomi T, et al.: Quantitative analysis of interferon alpha/beta receptor mRNA in the liver of patients with chronic hepatitis C: Correlation with serum hepatitis C virus-RNA levels and response to treatment with interferon. J Gastroenterol Hepatol 12:460-467, 1997